KUKJE PHARMA Co., Ltd. (002720.KS) KSC

Currency In KRW

AD

Valuation

Market Cap87.65B
Enterprise Value107.35B
P/E Ratio11.83
PEG Ratio0.31
Price/Sales Ratio0.41
Price/Book Ratio0.74
Enterprise/Revenue0.53
Enterprise/EBITDA9.57

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.03
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue175.5B
Revenue/Share8,410.83
Gross Profit92.97B
EBITDA9.41B
Net Income5.7B
Diluted EPS279.51

Balance Sheet

Total Cash9.38B
Total Cash/Share443.16
Total Debt30.92B
Total Debt/Equity0.31
Current Ratio1.09
Book Value Per Share4,655.23

Price History

52-Week Change-29.99
52-Week High5,470
52-Week Low3,115
Moving Average 50 Days3,761.6
Moving Average 200 Days4,334.18

Statistics

Average Volume115,758
Shares Outstanding21.16M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate30
Trailing Annual Dividend Yield0.87
Payout Ratio0.1
Last Split Factor21:20
Last Split DateMarch 17, 2023
AD